KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Assets Average (2016 - 2025)

Historic Assets Average for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to $1.4 billion.

  • Pacira BioSciences' Assets Average fell 1053.09% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 1053.09%. This contributed to the annual value of $1.6 billion for FY2024, which is 392.2% down from last year.
  • Per Pacira BioSciences' latest filing, its Assets Average stood at $1.4 billion for Q3 2025, which was down 1053.09% from $1.6 billion recorded in Q2 2025.
  • Pacira BioSciences' Assets Average's 5-year high stood at $2.0 billion during Q1 2022, with a 5-year trough of $1.3 billion in Q1 2021.
  • Its 5-year average for Assets Average is $1.6 billion, with a median of $1.6 billion in 2025.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 5504.68% in 2021, then crashed by 1921.46% in 2023.
  • Quarter analysis of 5 years shows Pacira BioSciences' Assets Average stood at $1.7 billion in 2021, then fell by 0.46% to $1.7 billion in 2022, then fell by 8.98% to $1.6 billion in 2023, then dropped by 1.08% to $1.5 billion in 2024, then decreased by 7.82% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.6 billion during Q1 2025.